Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500113824Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial of tegilerdin in postoperative pain (2 arms), sponsored by Second Affiliated Hospital of Kunming Medical University. Primary endpoint: Use of rescue analgesics. Planned start Dec 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500113824.